These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22444165)

  • 21. Vaccination of adults with asthma and COPD.
    Pesek R; Lockey R
    Allergy; 2011 Jan; 66(1):25-31. PubMed ID: 20716316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use.
    Toltzis P; Jacobs MR
    Infect Dis Clin North Am; 2005 Sep; 19(3):629-45. PubMed ID: 16102653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antipneumococcal vaccine: up date and prospective].
    Caramia G; Pastorelli G
    Minerva Pediatr; 2005 Oct; 57(5):229-41. PubMed ID: 16205607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pneumococcal vaccine in the prevention of community-acquired pneumonia: a skeptical view of cost-effectiveness.
    Simberkoff MS
    Semin Respir Infect; 1993 Dec; 8(4):294-9. PubMed ID: 7938926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effectiveness of pneumococcal polysaccharide vaccine in older patients with chronic respiratory diseases].
    Watanuki Y; Takahashi H; Ogura T; Miyazawa N; Nakamura M; Hashizume T; Kozawa S; Tagawa A
    Nihon Kokyuki Gakkai Zasshi; 2006 Apr; 44(4):305-11. PubMed ID: 16681246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults.
    Metlay JP; Fishman NO; Joffe M; Edelstein PH
    Vaccine; 2006 Jan; 24(4):468-75. PubMed ID: 16125826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical efficacy of pneumococcal vaccination--a prospective study in patients with longstanding emphysema and/or bronchitis.
    Franzen D
    Eur J Med Res; 2000 Dec; 5(12):537-40. PubMed ID: 11147998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic vaccinations in chronic obstructive pulmonary disease: current status.
    Varkey JB; Varkey AB; Varkey B
    Curr Opin Pulm Med; 2009 Mar; 15(2):90-9. PubMed ID: 19532022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: a matched case-control study.
    Vila-Corcoles A; Salsench E; Rodriguez-Blanco T; Ochoa-Gondar O; de Diego C; Valdivieso A; Hospital I; Gomez-Bertomeu F; Raga X
    Vaccine; 2009 Mar; 27(10):1504-10. PubMed ID: 19171174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study.
    Ansaldi F; Turello V; Lai P; Bastone G; De Luca S; Rosselli R; Durando P; Sticchi L; Gasparini R; Delfino E; Icardi G
    J Int Med Res; 2005; 33(5):490-500. PubMed ID: 16222881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumococcal pneumonia and influenza: a deadly combination.
    Klugman KP; Chien YW; Madhi SA
    Vaccine; 2009 Aug; 27 Suppl 3():C9-C14. PubMed ID: 19683658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
    Pavia M; Bianco A; Nobile CG; Marinelli P; Angelillo IF
    Pediatrics; 2009 Jun; 123(6):e1103-10. PubMed ID: 19482744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pneumococcal vaccination in obstructive lung diseases -- what can we expect?].
    Rose M; Lode H; de Roux A; Zielen S
    Dtsch Med Wochenschr; 2005 Mar; 130(9):461-5. PubMed ID: 15731959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Is polysaccharide pneumococcal vaccine effective in adults?].
    Møller K; Kronborg G; Dirksen A
    Ugeskr Laeger; 2001 Oct; 163(44):6112-7. PubMed ID: 11715153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pneumococcal vaccination in the prevention of community-acquired pneumonia: an optimistic view of cost-effectiveness.
    Fedson DS
    Semin Respir Infect; 1993 Dec; 8(4):285-93. PubMed ID: 7938925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pneumococcal vaccines: World Health Organization position paper.
    Can Commun Dis Rep; 1999 Sep; 25(17):150-1. PubMed ID: 10513118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
    Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
    Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease.
    Hammitt LL; Bruden DL; Butler JC; Baggett HC; Hurlburt DA; Reasonover A; Hennessy TW
    J Infect Dis; 2006 Jun; 193(11):1487-94. PubMed ID: 16652275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study.
    Vila-Córcoles A; Ochoa-Gondar O; Hospital I; Ansa X; Vilanova A; Rodríguez T; Llor C;
    Clin Infect Dis; 2006 Oct; 43(7):860-8. PubMed ID: 16941367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).
    ;
    MMWR Morb Mortal Wkly Rep; 2010 Sep; 59(34):1102-6. PubMed ID: 20814406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.